Healx

Series-B
healx.ai Biotech & Healthcare Cambridge, United Kingdom Founded 2014 51–100 employees
Total Funding $113M
Latest Round $47M Series-B
Last Announced Aug 1, 2024
Investors 15 Backers
Decision Makers 6 Available

About Healx

Building the world’s first AI-native rare disease pharma. End-to-end.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B
Global Headquarters Cambridge, United Kingdom
Year Founded 2014
Team Size 51–100 employees
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website healx.ai
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @healx (2.6K followers)
LinkedIn Corporate Company Profile

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Raised $47,000,000 · Series-B

    Backed by Atomico

  2. Capital Raise

    Raised $56,000,000 · Series-B

    Backed by Atomico

  3. Capital Raise

    Raised $10,000,000 · Series-A

    Backed by Balderton Capital

  4. Milestone

    Company founded

    Cambridge, United Kingdom

Investors & Backers

15
Atomico
Lead
Balderton Capital
Lead
Amadeus Capital Partners
Ayana capital
b2venture
Global Brain Corporation
Intel Capital
Jonathan Milner
O2h Ventures
Propel
R42 Group
Ruttenberg Gordon Investments
SCI Ventures
Trend Investment Group
VU Venture Partners

Funding History

3 Rounds
Series-B equity · Aug 1, 2024

Round backers: Atomico

Series-B equity · Oct 16, 2019

Round backers: Atomico

$56,000,000 venturebeat.com
Series-A equity · Jul 26, 2018

Round backers: Balderton Capital

$10,000,000 finsmes.com

Founders & Leadership

9

Andreas Bender

Founder

Work email & phone locked Unlock →

Anthony Hall

Chief Medical Officer

Work email & phone locked Unlock →

Christopher Moertel

Global Head of Clinical Development

Work email & phone locked Unlock →

David Brown

Founder

Work email & phone locked Unlock →

David Cavalla

Founder

Work email & phone locked Unlock →

David Warshawsky

Global Head of Metastatic Prevention

Work email & phone locked Unlock →

Ian Roberts

Director of Therapeutic Technology

Work email & phone locked Unlock →

Neil Thompson

Chief Scientific Officer

Work email & phone locked Unlock →

Tim Guilliams

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts